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Abstract
The Zn, Co, and Mn K-edge extended X-ray absorption fine structure (EXAFS) spectra of the N-acetyl-l-ornithine
deacetylase (ArgE) from Escherichia coli, loaded with one or two equivalents of divalent metal ions (i.e.,
[Zn(II)_(ArgE)], [Zn(II)Zn(II)(ArgE)], [Co(II)_(ArgE)], [Co(II)Co(II)(ArgE)], [Mn(II)_(ArgE)], and [Mn(II)Mn(II)(ArgE)]),
were recorded. The Fourier transformed data (FT) for [Zn(II)_(ArgE)], [Zn(II)Zn(II)(ArgE)], [Co(II)_(ArgE)] and
[Co(II)Co(II)(ArgE)] are dominated by a peak at 2.05 Å, that can be fit assuming five or six light atom (N,O)
scatterers. Inclusion of multiple-scattering contributions from the outer-shell atoms of a histidine-imidazole ring
resulted in reasonable Debye–Waller factors for these contributions and a slight reduction in the goodness-of-fit
value (f′). Furthermore, the data best fit a model that included a M–M vector at 3.3 and 3.4 Å for Zn(II) and
Co(II), respectively, suggesting the formation of a dinuclear site. Multiple scattering contributions from the
outer-shell atoms of a histidine-imidazole rings are observed at ~ 3 and 4 Å for Zn(II)- and Co(II)-loaded ArgE
suggesting at least one histidine ligand at each metal binding site. Likewise, EXAFS data for Mn(II)-loaded ArgE
are dominated by a peak at 2.19 Å that was best fit assuming six light atom (N,O) scatterers. Due to poor signal
to noise ratios for the Mn EXAFS spectra, no Mn–Mn vector could be modeled. Peak intensities for [M(II)_(ArgE)]
vs. [M(II)M(II)(ArgE)] suggest the Zn(II), Co(II), and Mn(II) bind to ArgE in a cooperative manner. Since no
structural data has been reported for any ArgE enzyme, the EXAFS data reported herein represent the first
structural glimpse for ArgE enzymes. These data also provide a structural foundation for the future design of
small molecules that function as inhibitors of ArgE and may potentially function as a new class of antibiotics.

Graphical abstract

The Zn, Co, and Mn K-edge EXAFS spectra of N-acetyl-L-ornithine deacetylase (ArgE) from E. coli are presented.
The Fourier transformed data for Zn(II) and Co(II)-loaded ArgE indicate five or six N,O scatterers at 2.05 Å and a
M-M vector at ~ 3.4 Å suggesting the formation of a dinuclear site.

Highlights

► The Zn, Co, and Mn K-edge EXAFS spectra of ArgE. ► EXAFS data for Zn(II) and Co(II) ArgE exhibit a peak at
2.05 Å, indicating five or six N,O scatterers. ► Inclusion of a M-M vector 3.4 Å for Zn(II) or Co(II) ArgE suggests
the formation of a dinuclear site. ► These data provide a structural base for the future design of small molecule
inhibitors of ArgE.
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1. Introduction

The emergence of antibiotic resistant bacterial infections has created a significant and growing medical problem
in the United States and throughout the world [1], [2], [3], [4], [5]. Currently available antibiotics work on
relatively few targets through mechanisms such as inhibiting protein or cell wall synthesis [6], [7], [8], [9].

Therefore, there is an urgent need to identify novel antibacterial targets and discover small molecule inhibitors
that can function as antimicrobial agents [10]. Based on bacterial genetic information, the arginine biosynthetic
pathway offers several potential antibacterial enzyme targets, some of which have yet to be explored [11], [12],
[13]. Prokaryotes synthesize arginine through a series of eight enzymatically-catalyzed reactions that differ from
those of eukaryotes by two key steps (Fig. 1): i) acetylation of glutamate (Step 1) and ii) the subsequent
deacetylation of the arginine precursor Nα-acetyl-l-ornithine (L-NAO) by the argE-encoded Nα-acetyl-l-ornithine
deacetylase (ArgE) (Step 5) [14], [15], [16]. The arginine biosynthetic pathway is found in all Gram-negative and
most Gram-positive bacteria including but not limited to Enterobacteriaceae, Haemophilus, Vibrionaceae,
Corynebacterium, Campylobacter, Yersinia pestis, Vibrio cholerae, Bacillus anthracis, Escherichia coli 0157:H7,
Shigella flexneri, Shigella typhimurium, and Neisseria gonorrhoeae [13], [14], [17], [18], [19], [20], [21], [22].
With the resurgence of antibiotic resistance in nearly all of these bacterial strains, the search for new antibiotics
that target hereto unexplored enzymes involved in metabolic processes exclusive to these bacteria is critically
important in order to renew our arsenal of antibiotics [23].

Fig. 1. Arginine biosynthetic pathway for prokaryotes.
Because ornithine is required, not only for the synthesis of arginine in bacteria, but also for polyamines involved
in DNA replication and cell division, the L-NAO deacetylation step is critical for bacterial proliferation [24].
Indeed, when Meinnel and coworkers transformed an arginine auxotrophic bacterial strain void of L-NAO
deacetylase activity with a plasmid containing argE, an Arg+ phenotype resulted [25]. However, when the start
codon (ATG) of argE in the same plasmid was changed to the Amber codon (TAG), the resultant plasmid was
unable to relieve arginine auxotrophy in the same cell strain. Therefore, ArgE is required for cell viability. Given
the fact that ArgE is only found in prokaryotes and is required for bacterial cell growth and proliferation, it
represents an enzymatic target for the development of a new class of antimicrobial agents [24].
All ArgE enzymes characterized to date require Zn(II) ions for enzymatic activity [12], [13], [26] and the amino
acid residues that function as metal ligands in the carboxypeptidase from Pseudomonas sp strain-RS-16 (CPG2),
the aminopeptidase from Aeromonas proteolytica (AAP), the dapE-encoded N-succinyl-l, l-diaminopimelic acid
desuccinylase from Haemophilus influenzae (DapE) [27], and the N-acetyl-l-citrulline deacetylase (ACD) from
Xanthomonas campestris [28], [29], [30] are strictly conserved in ArgE enzymes [12]. CPG2, DapE, and AAP
possess a (μ-aquo)(μ-carboxylato)dizinc(II) core with one terminal carboxylate and one histidine residue at each
metal site suggesting a similar active site exists in ArgE enzymes. The Zn–Zn distance is 3.4, 3.5, and 3.3 Å for
DapE, AAP, and CPG2, respectively, with each metal ion residing in a distorted tetrahedral coordination
geometry. Recently, kinetic and spectroscopic evidence suggested that the ArgE from E. coli also contains a
dinuclear metalloactive site [26]; however, no structural information regarding an ArgE enzyme has yet to be
reported. In order to provide evidence for a (μ-aquo)(μ-carboxylato)dizinc(II) core in ArgE enzyme, we have
obtained K-edge extended X-ray absorption fine structure (EXAFS) spectroscopic data on Zn(II), Co(II), and
Mn(II)-loaded ArgE from E. coli. Since EXAFS is sensitive to heavy atom scatterers in the second coordination
sphere, it is an effective tool for identifying dinuclear metal sites.

2. Materials and methods
2.1. Enzyme expression and purification

All chemicals used in this study were purchased from commercial sources and were of the highest quality
available. ArgE from E. coli was purified as previously described from a stock culture of E. coli BL21 Star™ cells
(Invitrogen) hosting the pET-27a(+)argE over-expression construct provided by Professor John S. Blanchard [12].
The purified enzyme manifested a single band, on a 12% SDS gel, which corresponds to its calculated Mr of
42,350, by comparison with molecular weight standards purchased from Sigma. It was subsequently
concentrated to > 1 mM and stored at 4 °C. Protein concentration was determined using the theoretical value
ε280 = 41,250 M− 1 cm− 1 [31]. Apo-ArgE samples were exchanged into 50 mM Chelex-100 treated HEPES buffer at
pH 7.5 and these samples were incubated anaerobically with MCl2 (99.999% Strem Chemicals) where M = Zn(II),
Co(II) or Mn(II) for ~ 20 min as previously reported [26].

2.2. Enzymatic assay of ArgE

Enzyme kinetic constants were determined in 50 mM Chelex-100 treated sodium phosphate buffer pH 7.5 with
L-NAO as the substrate at 25 °C. The rate of NAO deacetylation was monitored as a decrease in absorbance at
214 nm corresponding to the peptide bond (Δε214 = 103 M− 1 cm− 1). Catalytic activities were determined within
± 10%. The specific activity of purified ArgE with L-NAO was typically found to be 2000 units per mg of enzyme,
where one unit was defined as the amount of enzyme that releases 1 μmol of ornithine at 25 °C in 60 s. Initial
rates were fit directly to the Michaelis–Menten equation to obtain the catalytic constants Km and kcat.

2.3. X-ray absorption spectroscopy

XAS data were collected at the Stanford Synchrotron Radiation Lightsource (SSRL) with beam current between
80 and 100 mA at 3.0 GeV (Table 1). ArgE EXAFS samples (1 mM), loaded in polycarbonate cuvettes, 24 × 2 mm2
with one 24 × 2 mm2 face consisting of X-ray transparent Mylar tape, were flash-frozen in N2(l) and maintained at
10 K during data collection, using a liquid helium-flow cryostat. XAS fluorescence signals were collected with a
30-element intrinsic Ge solid-state detector and Z-1 fluorescence filters with Soller slits. The edge regions for
multiple scans obtained on the same sample were compared to ensure that the sample was not damaged by
exposure to X-ray radiation. Harmonic rejection was achieved by setting the cutoff energy of the focusing mirror
to an energy between the fundamental and second harmonic (10 keV for Mn, 12 keV for Co and 13 keV for Zn).
The energy was calibrated to the inflection points of the edge of the standard Zn, Co, and Mn foil, which were
assumed to be at 9660.7, 7709.5, and 6539.0 eV for Zn, Co and Mn, respectively.
Table 1. X-ray absorption data collection.
SR facility
Beamline
Current in storage ring
Monochromator crystal
Detection method
Detector type
Scan length, min
Scans in average
Temperature, K
Energy standard
Energy calibration, eV
E0, eV
Pre-edge background

Co EXAFS

SSRL
9–3
80–100 mA
Si[220]
Fluorescence
Solid state arraya
15
4
10
Co foil, 1st inflection
7709.5
7715

Zn EXAFS

SSRL
9–3
80–100 mA
Si[220]
Fluorescence
Solid state arraya
15
4
10
Zn foil, 1st inflection
9660.7
9670

Mn EXAFS

SSRL
9–3
80–100 mA
Si[220]
Fluorescence
Solid state arraya
15
4 to 7
10
Mn foil, 1st inflection
6539.0
6545

Energy range, eV
Gaussian center, eV
Gaussian width, eV
Spline background
Energy range, eV
(polynomial order)

0–7670
6930
750

0–9625
8638
750

0–6500
5898
750

7715.0–7947.47 (4) 9670.0–9898.63 (4) 6545.00–6778.03 (4)
7947.47–8179.95 (4) 9898.63–10127.3 (4) 6778.03–7011.06 (4)
8179.95–8412.42 (4) 10127.3–10355.9 (4) 7011.06–7244.09 (4)
a. The 30-element Ge solid-state X-ray fluorescence detector at SSRL was provided by the NIH
Biotechnology Research Resource.

XAS data reduction was carried out to extract the EXAFS using EXAFSPAK software [32] and the theoretical phase
and amplitude functions were calculated with FEFF8.0 [33]. The structural model for FEFF calculation was
generated based on the (μ-aquo)(μ-carboxylato)dizinc(II) site in the high-resolution crystallographic data for AAP
[29]. The Co model for calculation was based on this Zn–Zn model with Co–O distances around 2.05 Å. Because
optimization of distances and Debye–Waller factors for all shells is impossible with such a complicated model,
simulations relied on calculated Debye–Waller factors, which required determination of force constants for all
bond–atom pairs. The recursion method incorporated into FEFF was subsequently employed to calculate
Debye–Waller factors from force constants. All force constants were calculated via the UFF force field [34],
except those for Zn–Nimid, Co–Nimid, and Mn–Nimid as well as C C and C N bonds within imidazole rings. These
required DFT calculations based on vibrational frequencies [35], [36]. For metal–ligand force constant
calculations, the values calculated by UFF were halved, as the original values are known to be too large [37].
Multiple scattering analysis was performed as previously described [38]. Both single- and multiple-scattering
paths ≤ 4.5 Å from either the Mn(II), Zn(II) or Co(II) atoms were used to identify and quantify imidazole
coordination due to histidine. With calculated Debye–Waller factors and the amplitude and phase function of
the absorbing and scattering atom, the EXAFS were simulated by allowing only Eo optimization by EXAFSPAK.
The structural model was then manually tuned to optimize the comparison of simulated and observed EXAFS.

3. Results

Zinc, cobalt and manganese K-edge X-ray absorption spectra (XAS) of 1 mM samples of ArgE with one or two
equivalents of added Co(II) (i.e. [Co(II)_(ArgE)] and [Co(II)Co(II)(ArgE)]), Zn(II) (i.e. [Zn(II)_(ArgE)] and
[Zn(II)Zn(II)(ArgE)]) or Mn(II) (i.e. [Mn(II)_(ArgE)] and [Mn(II)Mn(II)(ArgE)]) are shown in Fig. 2, Fig. 3. Kinetic data
were obtained for all EXAFS samples prior to data collections. kcat and Km values obtained for ArgE in the
presence of one equivalent of Zn(II) towards N-acetyl-l-ornithine (NAO) were found to be 1600 s− 1 and 0.8 mM,
respectively, while the addition of a single equivalent of Co(II) provided kcat and Km values of 3800 s− 1 and
1.2 mM, respectively. These data are identical to those previously reported [26]. For fully loaded samples (e.g.
[Co(II)Co(II)(ArgE)], [Zn(II)Zn(II)(ArgE)], or [Mn(II)Mn(II)(ArgE)]), the EXAFS data reveal an average of both metal
ion environments. For [Co(II)_(ArgE)] and [Co(II)Co(II)(ArgE)], the spectra reveal 1s → 3d pre-edge transitions
that occur at 7709 eV with a normalized peak intensity of 0.048 for both (Fig. 2, inset). For both [Mn(II)_(ArgE)]
and [Mn(II)Mn(II)(ArgE)], the 1s → 3d pre-edge transitions reside in nearly the identical position and exhibit
identical shapes but differ in amplitude (Fig. 3, inset). The pre-edge feature (6541 eV) is weak, indicating a high
coordination number and symmetric geometry like the Co edge. Since 1s → 3d pre-edge transitions are Laporteforbidden in centrosymmetric environments (e.g., octahedral, but not tetrahedral), the intensity of the 1s → 3d
pre-edge transitions is inversely proportional to coordination number (assuming tetrahedral four-coordination).
The intensities of the observed transitions for both [Co(II)_(ArgE)] and [Co(II)Co(II)(ArgE)] and [Mn(II)_(ArgE)]
and [Mn(II)Mn(II)(ArgE)] are consistent with, on average, five- or six-coordinate divalent metal sites [39], [40].

Fig. 2. X-ray absorption K-edge spectra for [Co(II)_(ArgE)] (solid) and [Co(II)Co(II)(ArgE)] (dotted) (top) and
[Zn(II)_(ArgE)] (solid) and [Zn(II)Zn(II)(ArgE)] (dotted) (bottom). The inset in the top panel highlights the preedge
1s → 3d transitions for [Co(II)_(ArgE)] (solid) and [Co(II)Co(II)(ArgE)] (dotted).

Fig. 3. X-ray absorption K-edge spectra for [Mn(II)_(ArgE)] (solid) and [Mn(II)Mn(II)(ArgE)] (dotted). The inset
highlights the preedge 1s → 3d transitions for [Mn(II)_(ArgE)] (solid) and [Mn(II)Mn(II)(ArgE)] (dotted).
The dominant peak in the Fourier transformed (FT) EXAFS data for [Co(II)_(ArgE)] is centered at 2.11 Å and at
2.10 Å for [Co(II)Co(II)(ArgE)] with amplitude values of 1.78 and 1.61 respectively (Fig. 4; Table 2). Smaller peaks
were also noted at 3.1 Å, 3.4 Å and 4.1 Å with amplitude values of 0.47, 0.14 and 0.32, respectively, for
[Co(II)_(ArgE)]. Additional peaks were observed in the FT EXAFS data for [Co(II)Co(II)(ArgE)] at 3.2, 3.4 and 4.1 Å
with amplitude values of 0.49, 0.38 and 0.22, respectively. Excellent single-shell fits of EXAFS spectra for both
[Co(II)_(ArgE)] and [Co(II)Co(II)(ArgE)] were obtained with 5 ± 1 N/O scatterers at 2.05 Å. A second shell feature
at ca. 3.4 Å appears in the [Co(II)Co(II)(ArgE)] EXAFS spectrum. Fits incorporating a Co–Co interaction at 3.4 Å for
[Co(II)Co(II)(ArgE)] exhibit reasonable Debye–Waller factors (Table 2) and resulted in a significant improvement
in goodness-of-fit values (f′). Failure to incorporate a Co–Co vector in the curve-fitting parameters resulted in a
large disagreement between the data and simulation. Therefore, the second-shell FT feature observed at 3.4 Å is
consistent with the formation of a dinuclear Co(II) active site in ArgE.

Fig. 4. k3-weighted Co EXAFS (top) and Fourier transforms (bottom, over k = 2–12 Å− 1) for [Co(II)_(ArgE)]
experimental (black) and simulation (green) and for [Co(II)Co(II)(ArgE)] experimental (red) and simulation (blue).
Table 2. Parameters for simulation of Co and Zn ArgE EXAFSa.
Shell

Ras (Å) σas2 (Å2) ΔE0 (eV)
f′b
CoCo(II)_ArgE
Co–NHis
2.04
0.0028 10.5
0.100
CRC0B, 2–12 Å− 1 Co–Owater
2.05
0.0033
∆ k3χ = 11.37
Co–Obridged carboxylate 2.04
0.0026
Co–Ocarboxylate
2.04
0.0033
Co–Ocarboxylate
2.32
0.0035
Co–Co
3.37
0.0042
ZnZn_ArgE
Zn–NHis
2.01
0.0030 8.4
0.136
ZRZ0A, 2–12 Å− 1 Zn–Owater
2.00
0.0027
∆ k3χ = 10.51
Zn–Obridged carboxylate 2.05
0.0036
Zn–Ocarboxylate
1.99
0.0036
Zn–Ocarboxylate
2.32
0.0039
Zn–Zn
3.28
0.0044
a. Here a small part of paths used in simulation are listed. The simulation of Co ArgE includes 54 single and
multiple scattering paths while 57 scattering paths in Zn ArgE. Ras is the metal–scatterer distance from
corresponding molecular model. σas2 is a mean square deviation in Ras, calculated using UFF model. ΔE0 is
the shift in E0 for the theoretical scattering functions.
b. f′ is a normalized error (chi-squared)
Similar to [Co(II)_(ArgE)] and [Co(II)Co(II)(ArgE)], the FT EXAFS spectra of [Zn(II)_(ArgE)] and [Zn(II)Zn(II)(ArgE)]
are dominated by a peak at 2.05 Å (Fig. 5; Table 2). However, the amplitude values for this peak are quite similar
for [Zn(II)_(ArgE)] and [Zn(II)Zn(II)(ArgE)] (1.56 and 1.50 respectively), suggesting that Zn(II) ions bind to ArgE in a
similar manner as Co(II). Additional peaks are observed at 3.0 Å, 3.5 Å and 3.9 Å for [Zn(II)_(ArgE)] and

[Zn(II)Zn(II)(ArgE)], with intensity values of 0.29, 0.33 and 0.26 for [Zn(II)_(ArgE)] and 0.29, 0.40 and 0.26 for
[Zn(II)Zn(II)(ArgE)], respectively. Excellent simulations of the observed EXAFS spectra for both [Zn(II)_(ArgE)] and
[Zn(II)Zn(II)(ArgE)] were obtained with 5 ± 1 N/O scatterers at 2.00 Å. A second shell feature at ca. 3.3 Å is also
present in the EXAFS spectrum of [Zn(II)Zn(II)(ArgE)]. Fits incorporating a Zn–Zn interaction at 3.3 Å for
[Zn(II)Zn(II)(ArgE)] exhibited reasonable Debye–Waller factors (Table 2) and resulted in a significant
improvement in goodness-of-fit values (f′). Failure to incorporate a Zn–Zn vector in the curve-fitting parameters
resulted in a large disagreement between the data and simulation. Therefore, the second-shell FT feature
observed at 3.3 Å is consistent with a dinuclear Zn(II) active site in ArgE.

Fig. 5. k3-weighted Zn EXAFS (top) and Fourier transforms (bottom, over k = 2–12 Å− 1) for [Zn(II)_(ArgE)]
experimental (black) and simulation (green) and for [Zn(II)Zn(II)(ArgE)] experimental (red) and simulation (blue).
Interestingly, the FT EXAFS spectra of [Mn(II)_(ArgE)] and [Mn(II)Mn(II)(ArgE)] are dominated by a peak at 2.19 Å
(Fig. 6; Table 3) which resides at a significantly longer distance than that observed for either Zn(II) or Co(II)bound ArgE. The amplitudes of this peak for both [Mn(II)_(ArgE)] and [Mn(II)Mn(II)(ArgE)] are quite similar
(Fig. 6) suggesting that Mn(II) ions also bind to ArgE in a similar manner as Zn(II) and Co(II). Simulations of the
observed EXAFS spectra for both [Mn(II)_(ArgE)] and [Mn(II)Mn(II)(ArgE)] were obtained with 6 ± 1 N/O
scatterers at 2.19 Å. However, compared to the EXAFS data obtained for Zn(II) and Co(II)-loaded ArgE, the EXAFS
data for Mn(II) are of lower quality making it difficult to identify a possible Mn–Mn interaction or histidine
ligation (notice the similar height of FT peaks in the 3–4 Å region and the noise). It should be noted, that there is
a visible shoulder at ~ 4 Å− 1 in the EXAFS data for both [Mn(II)_(ArgE)] and [Mn(II)Mn(II)(ArgE)], which suggests
the presence of histidine ligands.

Fig. 6. k3-weighted Mn EXAFS (top) and Fourier transforms (bottom, over k = 2–12 Å− 1) for [Mn(II)_(ArgE)] (solid)
and [Mn(II)Mn(II)(ArgE)] (dotted).
Table 3. Curve fitting results for ArgE Mn K-edge EXAFSa.
Sample, filename (k range) ∆k3χ Fit Shell Ras (Å) σas2 (Å2) ΔE0 (eV)
f′b
[Mn(II)_(ArgE)]c
1
Mn–O5 2.18
0.0061 1.39
0.229
(k = 2 − 11 Å–1)
2
Mn–O6 2.18
0.0082 1.33
0.248
3
∆k χ = 14.05
[Mn(II)Mn(II)(ArgE)]c
3
Mn–O5 2.18
0.0044 1.75
0.141
–1
(k = 2 − 11 Å )
4
Mn–O6 2.18
0.0063 1.65
0.161
∆k3χ = 13.89
a. Shell is the chemical unit defined for the multiple scattering calculation. Subscripts denote the number
of scatterers per metal. Ras is the metal–scatterer distance. σas2 is a mean square deviation in Ras. ΔE0 is
the shift in E0 for the theoretical scattering functions.
b. f′ is a normalized error (chi-squared):
c. The fits for Mn ArgE use the smoothed data.
Inclusion of multiple-scattering contributions from the outer-shell atoms of a histidine-imidazole ring for the FT
features observed at ~ 3 and 4 Å for [Co(II)_(ArgE)], [Co(II)Co(II)(ArgE)], [Zn(II)_(ArgE)], and [Zn(II)Zn(II)(ArgE)],
resulted in reasonable Debye–Waller factors for these contributions and a slight reduction in f′ (Table 2). These
fits are similar to those reported for the FT EXAFS spectra of AAP and DapE [41]. The X-ray crystal structures of
AAP and DapE reveal a (μ-aquo)(μ-carboxylato)dizinc(II) active site containing one histidine residue bound to
each Zn(II) ion [27], [42]. The amplitude values for the features observed at ~ 3 and 4 Å are distinct for
[Zn(II)_(DapE)] vs. [Zn(II)Zn(II)(DapE)] and [Zn(II)_(AAP)] vs. [Zn(II)Zn(II)(AAP)] [41], but are similar for
[Zn(II)_(ArgE)] vs. [Zn(II)Zn(II)(ArgE)] (Fig. 7) suggesting that divalent metal ions bind to ArgE in a positive
cooperative manner.

Fig. 7. Non-phase corrected Fourier transforms over k = 2–12 Å− 1 for [Zn(II)_(ArgE)] (bottom; solid) and
[Zn(II)Zn(II)(ArgE)] (bottom; dotted), for [Zn(II)_(DapE)] (middle; solid) and [Zn(II)Zn(II)(DapE)] (middle; dotted)
and for [Zn(II)_(AAP)] (top; solid) and [Zn(II)Zn(II)(AAP)] (top; dotted).

4. Discussion
The evolution of bacterial resistance to antibiotics poses an imminent health threat to humans. The arginine
biosynthetic pathway offers several potential anti-bacterial targets that have yet to be explored (Fig. 1) [14],
[15], [25], [43]. Since ArgE is critical to bacterial cell survival and proliferation, and no ArgE homolog is produced
by humans, this enzyme holds great promise as a new antibiotic target. To date, no X-ray crystallographic data
have been reported for any ArgE enzyme and no catalytically important amino acid residues have been
identified. Therefore, the catalytically competent mono- and di-Zn(II), Co(II) and Mn(II)-loaded forms of ArgE
were examined by extended X-ray absorption fine structure (EXAFS) spectroscopy. EXAFS is particularly well
suited to clarify the structures of dinuclear metalloenzymes since EXAFS data are sensitive to heavy atom
scatterers in the second coordination sphere providing direct evidence for dinuclear sites, if they exist [44], [45].
The EXAFS 1s → 3d pre-edge transitions observed Co(II)-loaded ArgE at 7709 eV for both the mono- and
dinuclear Co(II) ArgE enzymes, are consistent with Co(II) residing in five or six-coordinate geometries [39], [40].
These data are in good agreement with previously reported electronic absorption spectra of Co(II)-loaded ArgE
[26]. For [Co(II)_(ArgE)], three distinct peaks at 560, 619 and 705 nm with molar absorptivities (ε) of
ε560 = 114 M− 1 cm− 1, ε619 = 119 M− 1 cm− 1 and ε705 = 52 M− 1 cm− 1 were observed. Addition of a second equivalent
of Co(II) to [Co(II)_(ArgE)] increased the intensity of each of the observed absorption bands providing ε values of
ε560 = 229 M− 1 cm− 1, ε619 = 290 M− 1 cm− 1 and ε705 = 121 M− 1 cm− 1. These data suggest that both Co(II) binding
sites in ArgE are five coordinate. Similarly, EPR spectra of [Co(II)_(ArgE)] and [Co(II)Co(II)(ArgE)] revealed the
presence of three species termed the Rhombic, Axial, and Dicobalt signals [26]. The predominant signal
observed from [Co(II)_(ArgE)] is the Rhombic signal, which exhibits high rhombic distortion of the axial zero-field
splitting parameter, suggestive of a highly axially asymmetric ligand field. The Rhombic signal also exhibits
resolved 59Co hyperfine structure, indicative of low strains in the spin Hamiltonian parameters, i.e. of a site with
a low degree of conformational freedom. Taken together EXAFS, UV–vis, and EPR data suggest a low symmetry

site, likely five-coordinate, with a geometry constrained by inflexible protein bound ligands. For
[Co(II)Co(II)(ArgE)], a second, broad signal (the Dicobalt signal) is observed and this signal increases in intensity
between the addition of one and two equivalents of Co(II); at the same time, both the intensity of the Rhombic
signal and the total intensity of the spectrum decrease with added Co(II). The increase in the Dicobalt signal and
concomitant decrease in the Rhombic signal are indicative of the formation of a dinuclear center and a
consequent change in the electronic structure of the first-Co(II) binding site. These data are also similar to those
reported for two dinuclear metallohydrolases from family M28, AAP and DapE [46], [47], [48], [49]. For both AAP
and DapE, UV–vis, EPR, and EXAFS data indicate that the first metal binding site resides in a five-coordinate
geometry while the second is either five or six-coordinate.
Similar to Co(II)-loaded ArgE, the EXAFS 1s → 3d pre-edge transitions observed for Mn(II)-loaded ArgE at
6541 eV for both the mono- and di-nuclear Mn(II) and Co(II) ArgE enzymes are consistent with both Mn(II) sites
in ArgE residing in five or six-coordinate geometries (30). These data are consistent with previously reported EPR
data on Mn(II)-loaded ArgE where the EPR spectra of [Mn(II)_(ArgE)] and [Mn(II)Mn(II)(ArgE)] are similar except
that [Mn(II)Mn(II)(ArgE)] exhibits a more intense six-line pattern centered around 3500 G (A = 8.8 mT) and
additional features at 1200 and 2100 G [50]. These EPR spectra are characteristic of mononuclear Mn(II) ions
[50]. In addition, no appreciable change in any of the spectra over the temperature range 4–70 K was observed
and no features in the parallel mode spectra were observed that could not be accounted for by transitions due
to isolated mononuclear Mn(II). Moreover, the EPR spectrum of [Mn(II)Mn(II)(ArgE)] does not contain a wellresolved 45 G hyperfine splitting, typical of dinuclear Mn(II)–Mn(II) centers when recorded at pH 7.5, but such a
pattern is apparent in the spectrum of [Mn(II)Mn(II)(ArgE)] in 50 mM CAPS buffer at pH 10.0 [50]. These data
clearly indicate the formation of a dinuclear active site but only at high pH values, suggesting coordination of a
hydroxide ion is required to couple the Mn(II) ions. Such behavior is unique compared to that of
[Co(II)Co(II)(ArgE)], which was shown to be coupled by a hydroxide ion at physiological pH [26].
The phase-corrected FT EXAFS spectra of [Co(II)_(ArgE)] and [Co(II)Co(II)(ArgE)] are similar to those of Zn(II)loaded ArgE, which are dominated by a peak at ca. 2.05 Å. On the other hand, the phase-corrected FT EXAFS
spectra of [Mn(II)_(ArgE)] and [Mn(II)Mn(II)(ArgE)] are dominated by a peak at ca. 2.19 Å, which is significantly
longer than that observed for either Zn(II) or Co(II). Excellent single-shell fits of these first shell features for
[Mn(II)_(ArgE)], [Co(II)_(ArgE)] and [Zn(II)_(ArgE)] were obtained and indicate that 5 or 6 N/O scatterers per
Mn(II), Co(II) or Zn(II) ion exists at 2.19, 2.11 or 2.05 Å, respectively (Table 2, Table 3). Similarly, excellent singleshell fits of the first shell features observed in the EXAFS spectra of [Co(II)Co(II)(ArgE)], [Mn(II)Mn(II)(ArgE)], and
[Zn(II)Zn(II)(ArgE)] were obtained and also indicate 5 or 6 N/O scatterers per Co(II), Mn(II), or Zn(II) ion at 2.19,
2.19, and 2.05 Å, respectively (Table 2, Table 3). These fits provide the average metal–ligand distances at the
first metal site for [Co(II)_(ArgE)], [Mn(II)_(ArgE)], and [Zn(II)_(ArgE)], but are the average metal–ligand distances
for both sites in [Co(II)Co(II)(ArgE)], [Mn(II)Mn(II)(ArgE)], and [Zn(II)Zn(II)(ArgE)]. The 0.09 Å difference in the
dominant peak position in the phase-corrected FT spectra for Mn(II)-loaded ArgE vs. Co(II)- or Zn(II)-loaded ArgE,
indicates that the Mn(II) bond distances are slightly longer than those observed for either Co(II) or Zn(II). This
increase in bond distance likely represents the increased ionic radius for Mn(II) (0.97 Å) vs. Co(II) (0.89 Å) and
Zn(II) (0.87 Å) in octahedral geometries [51]. In addition, a higher coordination number and greater static order
for Mn(II)-loaded ArgE vs. Co(II)- and Zn(II)-loaded ArgE is consistent with the thermodynamic data generated
from Arrhenius plots for [Mn(II)_(ArgE)], [Zn(II)_(ArgE)] and [Co(II)_(ArgE)] [26], [50]. More negative entropy
values were observed for [Zn(II)_(ArgE)] and Co(II)_(ArgE)] (− 106 and − 66.0 J/mol· K, respectively) than for
[Mn(II)_(ArgE)] (− 34.5 J/mol K), suggesting more order is imposed on Zn(II)- and Co(II)-loaded ArgE active sites
during catalysis compared with the Mn(II)-loaded form. Furthermore, the rhombic EPR signal observed for
[Mn(II)_(ArgE)] exhibits well-resolved 55Mn hyperfine structure, indicating low strains in the spin Hamiltonian
parameters [50]. Weak 59Co hyperfine structure is also observed for [Co(II)_(ArgE)] suggesting that Co(II) also
binds with a somewhat low degree of conformational freedom [26].

The phase corrected FT EXAFS spectra of [Co(II)Co(II)(ArgE)] and [Zn(II)Zn(II)(ArgE)] include a feature at ~ 3.3 Å,
which is similar to that observed in the phase corrected FT EXAFS spectra of the crystallographically
characterized enzymes urease [52], AAP, and DapE [41] that contain dinuclear active sites. This feature was
modeled as a M–M interaction suggesting each of these enzymes contain a dinuclear active site. Indeed, when a
M–M vector is omitted from the EXAFS fits, significant disagreement between the observed data and the
simulation occurs. For both [Co(II)Co(II)(ArgE)] and [Zn(II)Zn(II)(ArgE)], excellent simulations of EXAFS spectra
were obtained with a M–M distance of 3.40 Å and 3.28 Å, respectively. Sequence alignment of several ArgE
genes with those of the crystallographically characterized AAP, DapE, and CPG2 enzymes indicates that all of the
amino acids that function as metal ligands in AAP, DapE, and CPG2 are strictly conserved in ArgEs [12], [27], [53],
[54]. The X-ray crystal structures of CPG2, DapE, and AAP reveal a (μ-aquo)(μ-carboxylato)dizinc(II) active site
with one terminal carboxylate and histidine residue bound to each metal ion [27], [28], [29]. Both Zn(II) ions in
AAP, DapE, and CPG2 reside in distorted tetrahedral or pentacoordinate geometries, with Zn–Zn distances of 3.5,
3.4, and 3.3 Å for AAP, DapE, and CPG2, respectively. EXAFS data obtained for [Zn(II)Zn(II)(AAP)] and
[Zn(II)Zn(II)(DapE)] also contain features at 3.27 and 3.39 Å, respectively, that can be modeled as a Zn–Zn vector
[41]. Combination of these data, indicates that ArgE enzymes contain a dinuclear Zn(II) active site. In addition,
based on the X-ray crystal structures and first shell EXAFS fits for [Zn(II)Zn(II)(AAP)] and [Zn(II)Zn(II)(DapE)] vs.
those of Zn(II)-, Co(II)-, and Mn(II)-loaded ArgE, we propose that one carboxylate and one histidine residue
reside at each Zn(II) site in ArgE and that the two Zn(II) ions are bridged by one carboxylate residue and a water
molecule (Fig. 8).

Fig. 8. Proposed active site of the ArgE from E. coli based on EXAFS data.
Interestingly, the phase corrected FT EXAFS spectrum of [Zn(II)_(ArgE)] could also be simulated with the
inclusion of a 3.28 Å Zn–Zn vector. The amplitude of the feature corresponding to the Zn–Zn vector in the phase
corrected FT EXAFS spectra of [Zn(II)_(ArgE)] and [Zn(II)Zn(II)(ArgE)] is striking. For DapE and AAP, the lack of a
feature in the 3 to 4 Å for the mono-Zn(II)-loaded form vs. a strong feature in this range for the dinuclear Zn(II)
enzymes has been attributed to sequential metal binding for the dinuclear site. Sequential binding has been
verified for DapE as X-ray crystal structures for both the mono- and dinuclear Zn(II) DapE enzymes have been
reported [27]. On the other hand, similar amplitudes for the feature in the 3 to 4 Å range for [Zn(II)_(ArgE)] and
[Zn(II)Zn(II)(ArgE)] suggest positive cooperativity in Zn(II) binding to ArgE. Similarly, the EXAFS features in the 3
to 4 Å range for both Mn(II)- and Co(II)-loaded ArgE also suggest positive cooperativity in divalent metal binding.
Taken together, these data suggest that divalent metal ions bind differently to ArgE than AAP or DapE even
though the active site ligands appear to be identical [12], [53]. Indeed, electronic absorption and EPR spectra for
[Zn(II)Co(II)(ArgE)] vs. [Co(II)Zn(II)(ArgE)] and [Mn(II)Zn(II)(ArgE)] vs. [Zn(II)Mn(II)(ArgE)] are identical, whereas
spectral data for [Zn(II)Co(II)(AAP)] and [Co(II)Zn(II)(AAP)] are distinct [47].
In conclusion, ArgE enzymes are potential molecular targets for a novel class of antibiotics. The observation that
ArgE is active in the presence of a broad variety of transition metals, including Zn(II), Co(II), or Mn(II),
underscores the critical nature of this enzyme to bacterial cell survival (i.e. limiting Zn(II) will not halt ArgE
activity because other divalent metal ions can substitute). The EXAFS data reported herein demonstrate that the

ArgE from E. coli forms a dinuclear metalloactive site in the presence of Zn(II), Co(II), and Mn(II). In addition,
multiple scattering contributions from the outer-shell atoms of a histidine-imidazole rings are observed at ~ 3
and 4 Å for Zn(II)- and Co(II)-loaded ArgE suggesting at least one histidine ligand at each metal binding site. Since
no structural data have been reported for any ArgE enzyme, the EXAFS data reported herein represent the
structural first glimpse into the active site of ArgE enzymes. Moreover, EXAFS data obtained for Zn(II)-, Co(II)-,
and Mn(II)-loaded ArgE indicate that each of these divalent metal ions binds in a positive cooperative manner, in
contrast to the metal binding properties of AAP and DapE [47], [49], [55]. Finally, these data provide a structural
foundation for the future design of small molecules that will function as inhibitors of ArgE and may potentially
function as a new class of antibiotics.
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